Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic
malignancy after hepatocellular carcinoma (HCC), accounting for 10% to 15% of primary …

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy
and is increasing in incidence. Long-term outcomes are optimized when patients undergo …

Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …

Introduction Intrahepatic cholangiocarcinoma (ICC) remains an uncommon disease with a
rising incidence worldwide. We sought to identify trends in therapeutic approaches and …

Objectives To examine the outcomes of a hepatectomy for intrahepatic cholangiocarcinoma
(IHC) and to clarify the prognostic impact of a lymphadenectomy and the surgical margin …

Background Despite complete resection, disease-free survival (DFS) of patients with
cholangiocarcinoma (CCA) is less than 65% after one year and not more than 35% after …

Objective: Define the optimal surgical margin in patients undergoing surgery for intrahepatic
cholangiocarcinoma (IHCC). Background Data: Surgery is the most effective treatment for …

Background Recurrence of intrahepatic cholangiocarcinoma (ICC) after curative resection is
common. Objective The aim of this study was to investigate the patterns, timing and risk …

The purpose of this study was to perform a meta-analysis and systematic review of the
clinical efficacy and safety of radiofrequency (RF) ablation in the treatment of intrahepatic …

Intrahepatic cholangiocarcinoma represents the second most common primary liver cancer
and is increasing in incidence. Most patients are diagnosed at an advanced, nonsurgical …